Article

Drug design for Influenza A virus subtype H1N1

2009-11-16

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0fd48ce6-972e-5b0d-95f0-1174e384fc04
DOI: 10.1016/j.jtice.2009.06.007

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Drug design for Influenza A virus subtype H1N1DOI 10.1016/j.jtice.2009.06.007Read

Antivirals targeting influenza A virus.Semantic proximity Read

Epitopes based drug design for dengue virus envelope protein: A computational approachSemantic proximity Read

Live attenuated influenza virus vaccines by computer-aided rational designSemantic proximity Read

Discovery of Entry Inhibitors for HIV-1 via a New De Novo Protein Design FrameworkSemantic proximity Read

Learning from structure-based drug design and new antivirals targeting the ribonucleoprotein complex for the treatment of influenzaSemantic proximity Read

Repurposing FDA-approved drugs against the “main protease” pivotal enzyme in COVID-19 virus using computer-aided drug design techniquesSemantic proximity Read

The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.Semantic proximity Read

H5N1 virus resistant to antiviral drug.Semantic proximity Read

AI-Based Antibody Design Targeting Recent H5N1 Avian Influenza StrainsSemantic proximity Read

NS1 protein as a novel anti-influenza target: Map-and-mutate antiviral rationale reveals new putative druggable hot spots with an important role on viral replication.Semantic proximity Read

DAPTEV: Deep aptamer evolutionary modelling for COVID-19 drug designSemantic proximity Read

Design of new chemical entities targeting both native and H275Y mutant influenza a virus by deep reinforcement learningSemantic proximity Read